Here’s what you should know.
1. Cardinal Health posted $35.19 billion in year-over-year revenues for 2017, an increase of 6.1 percent.
2. The company’s medical segment specifically increased 18.6 percent year over year in 2017 to post $31.6 billion in revenues.
3. Cardinal also authorized a share repurchasing program of up to $1 billion of the company’s common shares, which will expire Dec. 31, 2020.
4. Zacks analysts believe the growth is somewhat sustainable attaching a ‘B’ rating to the company. The report said, “The company’s stock is suitable for value and momentum investors.”
More articles on supply chain:
UnitedHealth Group eyes 2nd ambulatory acquisition & more — 9 ASC company key notes
6 things to know about IBS
Oregon House passes extended recovery stay bill, allows ASC patients to stay 48 hours
